Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: David R. Colby who wrote (586)	12/19/1997 8:52:00 AM
From: Cymeed	Read Replies (1) \| Respond to of 887

Talking about lessons learned, I questioned the promise of DepoCyt myself when I saw heavy inside selling (Post #279), but I got myself past this critical doubt somehow and bought into this mess, based on second or even third hand information about the effects of the drug. People on this thread and probably the company too has treated FDA like a rubber stamp, thought FDA approval is something like getting a candy from your mom. Wrong, folks, we all got burnt because we never really evaluated the risk with our investment decision , we never even honestly, cautiously ask ouselves the question: what the consequence will be if FDA rejects. We tried not to think about that, which was deadly wrong. Lastly, "biotech" is a bunch of crabs in terms of investment "opportunity."